{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:19:26Z","timestamp":1770815966705,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36507-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:24:15Z","timestamp":1769016255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting dialyzer fiber blocking is hard due to high intrapatient variability and limited utility of thrombin generation markers"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6984-1743","authenticated-orcid":false,"given":"Sunny","family":"Eloot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Josipovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joke","family":"Konings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griet","family":"Glorieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E.","family":"Fredenburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Roest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"De Somer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan P.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu N.","family":"Boone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floris","family":"Vanommeslaeghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"36507_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/aor.13452","volume":"43","author":"F Vanommeslaeghe","year":"2019","unstructured":"Vanommeslaeghe, F. et al. Evaluation with micro-CT of different anticoagulation strategies during Hemodialysis in patients with thrombocytopenia: A randomized crossover study. Artif. Organs. 43, 756\u2013763 (2019).","journal-title":"Artif. Organs"},{"key":"36507_CR2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.ekir.2019.07.010","volume":"4","author":"F Vanommeslaeghe","year":"2019","unstructured":"Vanommeslaeghe, F. et al. Evaluation of different dialyzers and the impact of predialysis albumin priming in intermittent Hemodialysis with reduced anticoagulation. Kidney Int. Rep. 4, 1538\u20131545 (2019).","journal-title":"Kidney Int. Rep."},{"key":"36507_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/ckj\/sfz163","volume":"14","author":"F Vanommeslaeghe","year":"2021","unstructured":"Vanommeslaeghe, F. et al. A randomized cross-over study with objective quantification of the performance of an asymmetric triacetate and a polysulfone Dialysis membrane using different anticoagulation strategies. Clin. Kidney J. 14, 398\u2013407 (2021).","journal-title":"Clin. Kidney J."},{"key":"36507_CR4","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1038\/s41598-022-09696-7","volume":"12","author":"F Vanommeslaeghe","year":"2022","unstructured":"Vanommeslaeghe, F., Josipovic, I., Boone, M., Van Biesen, W. & Eloot, S. Impact of intradialytic fiber clotting on dialyzer extraction and solute removal: a randomized cross-over study. Sci. Rep. 12, 5717. https:\/\/doi.org\/10.1038\/s41598-022-09696-7 (2022).","journal-title":"Sci. Rep."},{"key":"36507_CR5","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/ckj\/sfaa219","volume":"14","author":"F Vanommeslaeghe","year":"2021","unstructured":"Vanommeslaeghe, F. et al. How biocompatible haemodialysers can conquer the need for systemic anticoagulation even in post-dilution haemodiafiltration: a cross-over study. Clin. Kidney J. 14, 1752\u20131759 (2021).","journal-title":"Clin. Kidney J."},{"key":"36507_CR6","first-page":"697","volume":"38","author":"M Puerta","year":"2025","unstructured":"Puerta, M. et al. SOLFA study: a multicenter, open-label, prospective, randomized study to investigate the clotting propensity of asymmetric cellulose triacetate membrane compared to synthetic membranes in on line HDF. J. Nephrol. 38, 697\u2013705 (2025).","journal-title":"J. Nephrol."},{"key":"36507_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1038\/s41598-018-20898-w","volume":"8","author":"F Vanommeslaeghe","year":"2018","unstructured":"Vanommeslaeghe, F. et al. Micro-computed tomography for the quantification of blocked fibers in hemodialyzers. Sci. Rep. 8, 2677. https:\/\/doi.org\/10.1038\/s41598-018-20898-w (2018).","journal-title":"Sci. Rep."},{"key":"36507_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/sdi.12932","volume":"34","author":"SE Claudel","year":"2021","unstructured":"Claudel, S. E., Miles, L. A. & Murea, M. Anticoagulation in hemodialysis: A narrative review. Semin Dial. 34, 103\u2013115 (2021).","journal-title":"Semin Dial"},{"key":"36507_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/ijlh.12665","volume":"39","author":"LA Linkins","year":"2017","unstructured":"Linkins, L. A. & Lapner, T. Review of D-dimer testing: Good, Bad, and ugly. Int. J. Lab. Hematol. 39, 98\u2013103 (2017).","journal-title":"Int. J. Lab. Hematol."},{"key":"36507_CR10","first-page":"1035","volume":"109","author":"M Franchini","year":"2023","unstructured":"Franchini, M., Focosi, D., Pezzo, P. & Mannucci, M. How we manage a high D\u2013dimer. Haematologica 109, 1035\u20131045 (2023).","journal-title":"Haematologica"},{"key":"36507_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ekir.2020.03.010","volume":"5","author":"K Fran\u00e7ois","year":"2020","unstructured":"Fran\u00e7ois, K. et al. Hemodialysis does not induce detectable activation of the contact system of coagulation. Kidney Int. Rep. 5, 831\u2013838 (2020).","journal-title":"Kidney Int. Rep."},{"key":"36507_CR12","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1055\/a-1450-8300","volume":"121","author":"J Wan","year":"2021","unstructured":"Wan, J., Konings, J., de Laat, B., Hackeng, T. M. & Roest, M. Added value of blood cells in thrombin generation testing. Thromb. Haemost. 121, 1574\u20131587 (2021).","journal-title":"Thromb. Haemost"},{"key":"36507_CR13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/jth.14786","volume":"18","author":"J Wan","year":"2020","unstructured":"Wan, J. et al. A novel assay for studying the involvement of blood cells in whole blood thrombin generation. J. Thromb. Haemost. 18, 1291\u20131301 (2020).","journal-title":"J. Thromb. Haemost"},{"key":"36507_CR14","doi-asserted-by":"publisher","unstructured":"Schamroth Pravda, M. et al. Blood stream infections in chronic Hemodialysis patients - characteristics and outcomes. BMC Nephrol. 25 https:\/\/doi.org\/10.1186\/s12882-023-03442-5 (2024).","DOI":"10.1186\/s12882-023-03442-5"},{"key":"36507_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.tcam.2012.06.003","volume":"27","author":"M O\u2019Brien","year":"2012","unstructured":"O\u2019Brien, M. The reciprocal relationship between inflammation and coagulation. Top. Companion Anim. Med. 27, 46\u201352 (2012).","journal-title":"Top. Companion Anim. Med."},{"key":"36507_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.thromres.2004.06.028","volume":"114","author":"CT Esmon","year":"2004","unstructured":"Esmon, C. T. The impact of the inflammatory response on coagulation. Thromb. Res. 114, 321\u2013327 (2004).","journal-title":"Thromb. Res."},{"key":"36507_CR17","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/S0049-3848(10)70153-5","volume":"127","author":"J Pet\u00e4j\u00e4","year":"2011","unstructured":"Pet\u00e4j\u00e4, J. Inflammation and coagulation. An overview. Thromb. Res. 127, S34\u201337 (2011).","journal-title":"Thromb. Res."},{"key":"36507_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon, C. T. The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417\u2013430 (2005).","journal-title":"Br. J. Haematol."},{"key":"36507_CR19","doi-asserted-by":"publisher","first-page":"15105","DOI":"10.1038\/s41598-023-42069-2","volume":"13","author":"S Eloot","year":"2023","unstructured":"Eloot, S., Vanommeslaeghe, F., Josipovic, I., Boone, M. & Van Biesen, W. Association between anticoagulation strategy and quality of life in chronic Hemodialysis patients. Sc Rep. 13, 15105. https:\/\/doi.org\/10.1038\/s41598-023-42069-2 (2023).","journal-title":"Sc Rep."},{"key":"36507_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.blre.2012.06.001","volume":"26","author":"R Al Dieri","year":"2012","unstructured":"Al Dieri, R., de Laat, B. & Hemker, H. C. Thrombin generation: what have we learned? Blood Rev. 26, 197\u2013203 (2012).","journal-title":"Blood Rev."},{"key":"36507_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1373\/jalm.2017.024083","volume":"2","author":"MB Pagano","year":"2017","unstructured":"Pagano, M. B. & Chandler, W. L. Thrombin generation assay: are we ready for prime time? J. Appl. Lab. Med. 2, 135\u2013137 (2017).","journal-title":"J. Appl. Lab. Med."},{"key":"36507_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","volume":"62","author":"A Tripodi","year":"2016","unstructured":"Tripodi, A. Thrombin generation assay and its application in the clinical laboratory. Clin. Chem. 62, 699\u2013707 (2016).","journal-title":"Clin. Chem."},{"key":"36507_CR23","first-page":"637","volume":"41","author":"RD Langdell","year":"1953","unstructured":"Langdell, R. D., Wagner, R. H. & Brinkhous, K. M. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J. Lab. Clin. Med. 41, 637\u2013647 (1953).","journal-title":"J. Lab. Clin. Med."},{"key":"36507_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1152\/ajplegacy.1935.114.2.282","volume":"114","author":"AJ Quick","year":"1935","unstructured":"Quick, A. J. On various properties of thromboplastin (aqueous tissue extracts). Am. J. Physiol. Leg. Content. 114, 282\u2013296 (1935).","journal-title":"Am. J. Physiol. Leg. Content"},{"key":"36507_CR25","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1046\/j.1538-7836.2003.00298.x","volume":"1","author":"KG Mann","year":"2003","unstructured":"Mann, K. G., Brummel, K. & Butenas, S. What is all that thrombin for? J. Thromb. Haemost. 1, 1504\u20131514 (2003).","journal-title":"J. Thromb. Haemost"},{"key":"36507_CR26","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.3390\/ijms232112772","volume":"23","author":"A Scridon","year":"2022","unstructured":"Scridon, A. Platelets and their role in hemostasis and thrombosis-from physiology to pathophysiology and therapeutic implications. Int. J. Mol. Sci. 23, 12772. https:\/\/doi.org\/10.3390\/ijms232112772 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"36507_CR27","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2012-05-427856","volume":"120","author":"MF Whelihan","year":"2012","unstructured":"Whelihan, M. F., Zachary, V., Orfeo, T. & Mann, K. G. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood 120, 3837\u20133845 (2012).","journal-title":"Blood"},{"key":"36507_CR28","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1182\/bloodadvances.2023010027","volume":"7","author":"S Sun","year":"2023","unstructured":"Sun, S. et al. Crucial roles of red blood cells and platelets in whole blood thrombin generation. Blood Adv. 7, 6717\u20136731 (2023).","journal-title":"Blood Adv."},{"key":"36507_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1182\/blood.2019001643","volume":"135","author":"F Denis","year":"2020","unstructured":"Denis, F. et al. Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways. Blood 135, 755\u2013765 (2020).","journal-title":"Blood"},{"key":"36507_CR30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/jth.13002","volume":"13","author":"GM Thomas","year":"2015","unstructured":"Thomas, G. M. et al. Tissue factor expressed by Circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. J. Thromb. Haemost. 13, 1310\u20131319 (2015).","journal-title":"J. Thromb. Haemost"},{"key":"36507_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood-2016-05-718114","volume":"128","author":"LL Swystun","year":"2016","unstructured":"Swystun, L. L. & Liaw, P. C. The role of leukocytes in thrombosis. Blood 128, 753\u2013762 (2016).","journal-title":"Blood"},{"key":"36507_CR32","doi-asserted-by":"publisher","first-page":"919495","DOI":"10.3389\/fcvm.2022.919495","volume":"9","author":"L Li","year":"2022","unstructured":"Li, L. et al. Patients with multiple myeloma have a disbalanced whole blood thrombin generation profile. Front. Cardiovasc. Med. 9, 919495. https:\/\/doi.org\/10.3389\/fcvm.2022.919495 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"36507_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jtha.2023.12.037","volume":"22","author":"RAL Willems","year":"2024","unstructured":"Willems, R. A. L. et al. Altered whole blood thrombin generation and hyperresponsive platelets in patients with pancreatic cancer. J. Thromb. Haemost. 22, 1132\u20131144 (2024).","journal-title":"J. Thromb. Haemost"},{"key":"36507_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/hdi.12788","volume":"24","author":"JF Matos","year":"2020","unstructured":"Matos, J. F. et al. Does subjective assessment of dialyzer appearance reflect dialyzer performance in online hemodiafiltration? Hemodial. Int. 24, 61\u201370 (2020).","journal-title":"Hemodial. Int."},{"key":"36507_CR35","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.echo.2019.08.015","volume":"32","author":"KV Bunting","year":"2019","unstructured":"Bunting, K. V. et al. A practical guide to assess the reproducibility of echocardiographic measurements. J. Am. Soc. Echocardiogr. 32, 1505\u20131515 (2019).","journal-title":"J. Am. Soc. Echocardiogr"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36507-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36507-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:22:48Z","timestamp":1770805368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36507-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36507"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36507-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"4 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.F., R.A., and E.P.M. are employees of Regeneron Pharmaceuticals and may hold stock in the company. The remaining authors do not have Competing Interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5913"}}